Kelly McGrail-Pokuta joins Prime Therapeutics as vice president, pharmacy trade relations

McGrail-Pokuta brings to Prime more than 25 years of combined experience in the healthcare and pharmaceutical industries

August 13, 2019
EAGAN, Minn. – Today Prime Therapeutics LLC (Prime), a total drug management company serving 23 Blue Cross and Blue Shield Plans with more than 28 million members nationally, welcomed Kelly McGrail-Pokuta as its vice president of pharmacy trade relations.

McGrail-Pokuta will oversee the strategic direction and management of all pharmaceutical manufacturer relationships in support of Prime’s Total Drug Management business model.

McGrail-Pokuta brings to Prime more than 25 years of combined experience in the healthcare and pharmaceutical industries. She has held leadership positions within OptumRx and Diplomat Pharmacy, plus program and product management positions with then CVS Caremark and pharmaceutical companies. Most recently she worked as a consultant in the pharmacy benefit management and pharmacy space.

“Kelly is a seasoned expert in managing the broad continuum of pharmaceutical manufacturer relationships necessary to drive innovative and successful outcomes in a rapidly changing environment” said Jarrod Henshaw, senior vice president, chief supply chain and industry relations officer for Prime. “Her broad experience will help us deliver on our total drug management commitment to our plans and our members, and we are thrilled to have her leading our trade relations efforts.”

McGrail-Pokuta holds a Doctor of Pharmacy degree from the University of Illinois at Chicago and completed her clinical pharmacy practice residency at the University of Illinois Hospital and Clinics.

Related news

Press releases

April 11, 2024

Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting

Press releases

March 13, 2024

Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance

Strategic alliance allows Prime to offer exclusive access to Capital Rx’s leading technology platform to achieve a higher standard of care, increase efficiency, improve experiences and provide the foundation for the next generation of integrated pharmacy care for the more than 50 million Americans served by Prime

Press releases

February 8, 2024

Magellan Rx Management, LLC earns URAC Accreditation in Health Utilization Management

Designation demonstrates highest level of commitment to quality health care